Please assess the completion status of the following clinical trial:

Trial Title: A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* willing to comply with investigator's and protocol's instructions~* patients signature on the informed consent document~* open-angle glaucoma or ocular hypertension~* currently prescribed timolol hemihydrate (once a day (QD) or twice a day (BID))or timolol maleate in sorbate QD as monotherapy or as a part of 2-drug therapy in at least one eye~Exclusion Criteria:~* inability to understand the trial procedures~* inability to give informed consent~* inability to understand, read, or write English~* best corrected visual acuity of 20/200 or worse in each eye~* current moderate to severe infectious or inflammatory condition of the eye or eyelids including~* current moderate to severe dry eye syndrome~* current chronic use of ocular corticosteroids, ocular surgery or intraocular laser surgery to either eye in the prior 3 months~* treated with 3 or more glaucoma medicines in both eye

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Timolol hemihydrate (Type: None): Subjects currently prescribed timolol hemihydrate 0.5% solution.
- Timolol maleate (Type: None): Subjects currently prescribed timolol maleate in sorbate.

Based on this trial design, predict the completion outcome and termination type (if applicable).